Back

PTFV1 is associated with functional atrial myopathy and atrial inflammation in HFpEF patients undergoing CABG

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: back to basics Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Rosa Hultsch

University Hospital Regensburg, Regensburg (Germany)

5 More presentations in this session

Presentation thumbnail
A multifactorial porcine model of cardio-metabolic HFpEF highlights miR-483-3p as a promising target therapy
Miss K. Wierling (German Heart Center Of Charite Berlin, DE)
Abstract Slides
Presentation thumbnail
Left atrioventricular coupling index predicts prognosis and pulmonary vascular dysfunction in heart failure with preserved ejection fraction
Ms E. Hasegawa (Toyonaka, JP)
Abstract Slides
Presentation thumbnail
Left atrial mechanics and ventilatory performance in HFpEF patients evaluated with simultaneous cardiopulmonary exercise test and stress echocardiography
Doctor M. Losito (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Аtrial cardiomyopathy as a determinant of stroke risk in heart failure with preserved ejection fraction and non-permanent atrial fibrillation
Associate Professor L. Hazarapetyan (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
NRAP marks adaptive premyofibril-like structures during pathological cardiac remodeling
Doctor T. Yang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: back to basics

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Multi-omics profiling identifies inflammation metabolism fibrosis crosstalk as a defining feature of HFpEF distinct from HFrEF
28 August 2026
thumbnail
Congress Presentation
P-wave morphology based diagnosis of atrial cardiomyopathy in heart failure with preserved ejection fraction (HFpEF) patients with and without known atrial fibrillation (AF)
30 March 2025
thumbnail
Congress Presentation
Prognostic significance of functional mitral regurgitation in patients with HFpEF and atrial fibrillation after optimal medical therapies
17 May 2025
thumbnail
Congress Presentation
Targeting CCR2+ macrophages and SPP1 in HFpEF: the promise of vagus nerve stimulation
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources